Literature DB >> 17116832

The relationship between melanoma thickness and time to diagnosis in a large population-based study.

Peter D Baade1, Dallas R English, Philippa H Youl, Michelle McPherson, J Mark Elwood, Joanne F Aitken.   

Abstract

OBJECTIVE: To examine the relationship between melanoma thickness and reported time from first recognition and from first physician contact to the diagnosis of invasive melanoma.
DESIGN: Telephone survey of patients recently diagnosed as having melanoma, combined with relevant pathological data (including melanoma thickness and morphologic structure) from the population-based Queensland Cancer Registry. A test-retest study (n = 176) was also conducted.
SETTING: Population-based study in Queensland. PARTICIPANTS: Residents of Queensland (n = 3772) who had been diagnosed as having invasive melanoma between January 1, 2000, and December 31, 2003. MAIN OUTCOME MEASURES: Prepresentation time (time between first noticing a suspicious spot and the first physician visit), postpresentation time (time between the first physician visit and diagnosis), and total time to diagnosis (time from initial detection of the melanoma to diagnosis).
RESULTS: With 1 exception, we found no significant association between melanoma thickness and reported time to diagnosis for all melanomas combined, superficial spreading melanomas, or nodular melanomas. The exception was a positive association between melanoma thickness and postpresentation delay of physician-detected nodular melanomas. The reliability study gave intraclass correlation coefficients of 0.85 to 0.90 for the measures of intervals.
CONCLUSIONS: This large study demonstrates no clear relationship between the melanoma thickness when diagnosed and the time from first recognition of changes or from first physician examination to diagnosis. This may be because of varying biological characteristics of melanomas, as well as methodological limitations of retrospective studies when trying to measure this complex association.

Entities:  

Mesh:

Year:  2006        PMID: 17116832     DOI: 10.1001/archderm.142.11.1422

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  16 in total

Review 1.  A new understanding in the epidemiology of melanoma.

Authors:  Esther Erdei; Salina M Torres
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

2.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

3.  Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.

Authors:  Ruzica Z Conic; Claudia I Cabrera; Alok A Khorana; Brian R Gastman
Journal:  J Am Acad Dermatol       Date:  2017-10-17       Impact factor: 11.527

4.  Neglected Basal cell carcinomas in the 21st century.

Authors:  Erika Varga; Irma Korom; Zoltán Raskó; Erika Kis; János Varga; Judit Oláh; Lajos Kemény
Journal:  J Skin Cancer       Date:  2010-11-25

5.  Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study.

Authors:  Fiona M Walter; Elka Humphrys; Simon Tso; Margaret Johnson; Simon Cohn
Journal:  BMC Fam Pract       Date:  2010-08-31       Impact factor: 2.497

Review 6.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

7.  Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study.

Authors:  Sally Jane O'Shea; Zoe Rogers; Fiona Warburton; Amanda J Ramirez; Julia A Newton-Bishop; Lindsay J L Forbes
Journal:  BMC Cancer       Date:  2017-01-03       Impact factor: 4.430

8.  Do diagnostic delays in cancer matter?

Authors:  R D Neal
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

9.  Health-care delay in malignant melanoma: various pathways to diagnosis and treatment.

Authors:  Senada Hajdarevic; Asa Hörnsten; Elisabet Sundbom; Ulf Isaksson; Marcus Schmitt-Egenolf
Journal:  Dermatol Res Pract       Date:  2014-01-05

10.  'This isn't what mine looked like': a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma.

Authors:  Fiona M Walter; Linda Birt; Debbie Cavers; Suzanne Scott; Jon Emery; Nigel Burrows; Gina Cavanagh; Rona MacKie; David Weller; Christine Campbell
Journal:  BMJ Open       Date:  2014-07-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.